Spironolactone and Breast Cancer: Fear Not!
July 2020
in “
Journal of the American Academy of Dermatology
”
Studysummary This analysis found that spironolactone use is not associated with an increased risk of breast cancer recurrence in female survivors.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jaad.org →